The efficacy of donepezil in Alzheimer's disease

Journal of Nippon Medical School

Volumn 69, Issue 4, 2002, Pages 379-382

  Ito, Takao ^a   Yamadera, Hiroshi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Alzheimer's Disease; Donepezil

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL;

AGED; ALZHEIMER DISEASE; ARTICLE; CASE REPORT; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFICACY; FEMALE; HUMAN; HYPERACTIVITY; RATING SCALE; TREATMENT OUTCOME;

AGED; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; FEMALE; HUMANS; INDANS; PIPERIDINES;

EID: 0036684252     PISSN: 13454676     EISSN: None     Source Type: Journal    
DOI: 10.1272/jnms.69.379     Document Type: Article

References (22)

1. Cholinesterase inhibitors: A new class of psychotropic compounds
2. A 24-week randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease
3. Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease
4. The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease
5. Treatment of dementia patients with psychotic and behavioral symptoms with quetiapine and donepezil
6. The relationship between donepezil and behavioral disturbances in patients with Alzheimer's disease
7. Adverse effects associated with the use of donepezil in general practice in England
8. The effects of donepezil in Alzheimer's disease: Results from a multinational trial
9. Donepezil improves symptoms of delirium in dementia: Implications for future research
10. Donepezil for postoperative delirium associated with Alzheimer's disease
11. Mania associated with donepezil
12. Pisa syndrome due to a cholinesterase inhibitor (Donepezil)
13. Behavioral complications associated with donepezil
14. The relationship between donepezil and behavioral disturbances in patients with Alzheimer's disease